Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. By week 26, cagrilintide resulted in significantly increased weight reduction compared to liraglutide and placebo. 2. Gastrointestinal adverse events, ...
1. Patients receiving tirzepatide (5, 10, or 15 mg) reported significantly greater reductions in HbA1c compared to daily insulin degludec ...
1. Standard BMI thresholds associated with greater risk of diabetes varied across 57 low- and middle-income countries depending on geographical ...
1. Mean BMI and obesity prevalence increased more rapidly between 2004-2010 than between 2010-2018. 2. Divergent trends were seen between ...
1. Matched cohort meta-analysis showed significant morality and life expectancy benefits with metabolic–bariatric surgery compared to non-surgical management of obesity. ...
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to ...
1. In a study examining childhood obesity in children ages 2 to 5 from 2003 to 2012, findings suggest that ...
Image: PD 1. 1 month complication rates in increasing order: laparoscopic-adjustable gastric banding (LAGB), sleeve gastrectomies (SG), laparoscopic gastric bypass ...
